GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-134 Cr | ₹-141 Cr | ₹-146 Cr | ₹-134 Cr | ₹-113 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-134 Cr |
| Mar2025 | ₹-141 Cr |
| Mar2024 | ₹-146 Cr |
| Mar2023 | ₹-134 Cr |
| Mar2022 | ₹-113 Cr |
How is Deferred Tax Assets / Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-134 Cr | Negative | |
| Mar2025 | ₹-141 Cr | Negative | |
| Mar2024 | ₹-146 Cr | Negative | |
| Mar2023 | ₹-134 Cr | Negative | |
| Mar2022 | ₹-113 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,722.2 Cr | -5.7% | -7.2% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -5.7% |
-7.2% |
3.9% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses